Hylan-G-F-20 for OA of the knee cost saving in US managed care

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.360, 2002-01, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hylan-G-F-20 for OA of the knee cost saving in US managed care

Inpharma, Vol. 1, Iss. 1334, 2002-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Hylan G-F 20 Single-Injection Formulation

By Frampton James E.

Drugs & Aging, Vol. 27, Iss. 1, 2010-01 ,pp. : 77-85

Adis International

Access to resources Recommend Favorite

Hylan G-F 20: Joint inflammation following intra-articular administration in an elderly patient?: case report

Reactions Weekly, Vol. 1, Iss. 1210, 2008-01 ,pp. : 18-19

Adis International

Access to resources Recommend Favorite

Hylan G F 20: Acute inflammatory flare following intra-articular administration: case report

Reactions Weekly, Vol. 1, Iss. 1425, 2012-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Meloxicam cost saving over piroxicam and diclofenac in OA

Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite